Literature DB >> 8968902

False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

O Liesenfeld1, C Press, J G Montoya, R Gill, J L Isaac-Renton, K Hedman, J S Remington.   

Abstract

Although tests for detection of immunoglobulin M (IgM) toxoplasma antibodies have been reported to have a high degree of accuracy, it is well recognized by investigators in the United States and Europe that false-positive results may occur with many of these tests, at times to an alarming degree. Unfortunately, this information is not well documented in the literature. Studies on various toxoplasma IgM test kits are frequently flawed. The investigators often use reference tests which have not previously been carefully evaluated as well as sera that were not appropriate to answer the question of how often false-positive results might occur. We recently had the unique opportunity to evaluate the accuracy of the Platelia Toxo IgM test in 575 serum samples obtained during an outbreak of toxoplasmosis which occurred in 1995 in the Capital Regional District of British Columbia, Canada. When compared with results obtained in a reference IgM enzyme-linked immunosorbent assay (ELISA), the Platelia Toxo IgM test had a sensitivity of 99.4%, specificity of 49.2%, positive predictive value of 51.9%, negative predictive value of 99.3%, and an overall agreement of 67.0%. In an attempt to resolve discrepancies between these two tests, a serological profile (Sabin-Feldman dye test, IgA and IgE antibody tests, differential agglutination [AC/HS] test, and IgG avidity method) was performed. Of 153 serum samples that were positive in the Platelia Toxo IgM test and negative in the IgM ELISA, 71 (46.4%) were negative in the Sabin-Feldman dye test. Of the serum samples that were positive in the dye test, 77 (93.9%) had a serological profile most compatible with an infection acquired in the distant past. These results reveal high numbers of false-positive results in the Platelia Toxo IgM test and highlight the importance of appropriate evaluation of commercial tests that are currently being marked. Our results also emphasize the importance of confirmatory testing to determine whether the results of an IgM antibody test reflect the likelihood of a recently acquired infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8968902      PMCID: PMC229533          DOI: 10.1128/jcm.35.1.174-178.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

Review 1.  Statistical methods in microbiology.

Authors:  D M Ilstrup
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Evaluation of three commercial enzyme immunoassays for toxoplasma and cytomegalovirus antibodies.

Authors:  R A Van Enk; K K James; K D Thompson
Journal:  Am J Clin Pathol       Date:  1991-03       Impact factor: 2.493

3.  Performance of European laboratories testing serum samples for Toxoplasma gondii.

Authors:  J C Petithory; I Reiter-Owona; F Berthelot; M Milgram; J De Loye; E Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

4.  IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  P Stepick-Biek; P Thulliez; F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

5.  [Evaluation of the Vidas system for the serological diagnosis of toxoplasmosis].

Authors:  H Pelloux; P Ciapa; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Ann Biol Clin (Paris)       Date:  1993       Impact factor: 0.459

6.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

7.  Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis.

Authors:  S Y Wong; M P Hajdu; R Ramirez; P Thulliez; R McLeod; J S Remington
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

8.  Studies on the serodiagnosis of toxoplasmic lymphadenitis.

Authors:  J G Montoya; J S Remington
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

9.  Diagnostic implications of kinetics of immunoglobulin M and A antibody responses to Toxoplasma gondii.

Authors:  M Gorgievski-Hrisoho; D Germann; L Matter
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

10.  Enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii based on enhanced chemiluminescence.

Authors:  C F Crouch
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

View more
  79 in total

1.  Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands.

Authors:  F Vlaspolder; P Singer; A Smit; R J Diepersloot
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey.

Authors:  Li Liang; Mert Döşkaya; Silvia Juarez; Ayşe Caner; Algis Jasinskas; Xiaolin Tan; Bettina E Hajagos; Peter J Bradley; Metin Korkmaz; Yüksel Gürüz; Philip L Felgner; D Huw Davies
Journal:  Mol Cell Proteomics       Date:  2011-04-21       Impact factor: 5.911

3.  VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Authors:  Jose G Montoya; Oliver Liesenfeld; Sandra Kinney; Cynthia Press; Jack S Remington
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

Review 4.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

6.  Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Authors:  Elisa Beghetto; Andrea Spadoni; Luca Bruno; Wilma Buffolano; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

7.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women.

Authors:  C Jost; F Touafek; A Fekkar; R Courtin; M Ribeiro; D Mazier; L Paris
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

9.  Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women.

Authors:  Pierre Flori; Laetitia Tardy; Hugues Patural; Bahrie Bellete; Marie-Noëlle Varlet; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.